Advanced Pathology Research & Diagnostic Innovation
Pioneering translational research in molecular diagnostics, immunopathology, and clinical biomarker discovery. Advancing precision medicine through rigorous scientific inquiry and peer-reviewed investigation.
Research Specialties
Our institute conducts advanced investigations across six core pathology disciplines, driving innovation in diagnostic science and translational medicine.
Molecular Diagnostics
Nucleic acid amplification, next-generation sequencing, and real-time PCR assays for pathogen detection, pharmacogenomics, and cancer mutation profiling.
Immunohistochemistry
Tissue-based biomarker expression studies using monoclonal antibody panels for cancer subtyping, prognostic stratification, and therapeutic target validation.
Clinical Microbiology
Antimicrobial resistance surveillance, pathogen whole-genome sequencing, and culture-independent diagnostic testing for infectious disease epidemiology.
Hematopathology
Morphologic and flow cytometric analysis of hematologic malignancies, coagulation disorder research, and bone marrow engraftment monitoring protocols.
Cytopathology
Fine-needle aspiration cytology research, liquid-based cytology validation, and AI-assisted screening algorithms for early neoplastic detection.
Molecular Genetics
Cytogenetic karyotyping, fluorescence in situ hybridization, and chromosomal microarray analysis for constitutional and acquired genetic disorder research.
Research Methodology & Lab Capabilities
A rigorous, peer-reviewed pipeline from hypothesis formulation through clinical translation, ensuring reproducible and publication-grade outcomes.
Hypothesis & Protocol Design
Literature synthesis, power analysis, and IRB-compliant protocol development with predefined primary and secondary endpoints.
Sample Processing & QC
Standardized pre-analytical workflows, chain-of-custody documentation, and multi-parameter quality control for specimen integrity.
Advanced Analytical Testing
High-throughput sequencing, mass spectrometry, digital pathology, and multiplex immunoassay platforms operated under GLP standards.
Data Validation & Peer Review
Biostatistical analysis, inter-laboratory concordance studies, and independent expert review prior to manuscript submission.
Research Processing Timelines
Standard and expedited analytical pipelines to accommodate grant deadlines, clinical trial milestones, and publication schedules.
Tissue sectioning, antigen retrieval, antibody optimization, and digital slide scanning with pathologist scoring.
DNA/RNA extraction, assay validation, triplicate runs, and statistical fold-change analysis with biological replicates.
Panel design, compensation matrix setup, acquisition on calibrated cytometers, and automated gating with manual review.
Single-plex ELISA or chemiluminescence assays for time-sensitive clinical trial enrollment or grant milestone reporting.
Library preparation, MiSeq or MinION nanopore run, and phylogenetic analysis for outbreak investigation support.
Sample QC, library construction, Illumina NovaSeq run, bioinformatics pipeline (GATK/DRAGEN), and variant annotation with ACMG classification.
Tissue optimization, Visium or Xenium slide processing, imaging, and computational mapping of gene expression to histological architecture.
Research Areas & Specialties
Our principal investigators lead multi-disciplinary programs spanning oncology, infectious disease, genetics, and chronic disease pathology.
Publications & Clinical Trials
Selected peer-reviewed manuscripts and active interventional studies led by our principal investigators and collaborative research networks.
Journal of Clinical Pathology (2024)
"Validation of a multiplex PCR panel for rapid detection of carbapenem-resistant Enterobacteriaceae in sub-Saharan African tertiary centers."
The Lancet Oncology (2023)
"Circulating tumor DNA dynamics predict pathologic complete response in neoadjuvant breast cancer therapy: a prospective biomarker study."
PLOS Neglected Tropical Diseases (2024)
"Genomic epidemiology of Lassa virus in West Africa: real-time nanopore sequencing for outbreak surveillance and phylogenetic mapping."
ACTIV-5 / Big Effect Trial (Phase III)
Multi-center randomized controlled trial evaluating host-directed immunomodulatory therapy in severe community-acquired pneumonia across 12 African sites.
Sickle Cell Genomics Consortium (Observational)
Longitudinal whole-genome sequencing study of 5,000 pediatric and adult patients to identify modifier loci associated with vaso-occlusive crisis frequency.
ENDO-Africa Diabetes Biobank (Cohort)
Prospective metabolic phenotyping and multi-omic profiling of 10,000 participants across East and West Africa to establish population-specific reference intervals.
Collaborate With Our Research Team
Submit a research inquiry, propose a partnership, or request sample analysis services. Our scientific affairs office will respond within two business days.
Our Impact in Numbers
Trusted by thousands of patients and leading medical consultants across the region.
Frequently Asked Questions
Do I need to fast before my blood test?
For most metabolic and lipid panels, fasting for 8-12 hours is required. You may drink water, but avoid coffee, tea, or food. Check your specific test instructions on the booking confirmation.
What should I bring for my sample collection?
Please bring a valid government-issued ID and your doctor's referral (if applicable). If you have a pre-paid booking, have your QR code ready on your mobile device.
How will I receive my results?
Results are primarily delivered via our secure online portal and encrypted email. You will receive an SMS notification as soon as your report is validated by our pathologist.
Are your labs certified for travel requirements?
Yes, Prime Pathology Clinic is fully certified by national health authorities and international bodies for all travel-related diagnostic screenings, including fit-to-fly certificates.